Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2006-04-18 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our board of directors since January 2004. From May 1999 to November 2003, he served as Chairman, Chief Executive Officer and President of Antigen Express, Inc., a development-stage company developing immunodiagnostics and therapeutics for cancer. Dr. Gulfo serves as a director of ProCertus BioPharm, Inc., a privately-held company. Dr. Gulfo received a B.S. in Biology from Seton Hall University, an M.D. from the University of Medicine and Dentistry of New Jersey and an M.B.A. in Finance from Seton Hall University. |
| 2009-04-17 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2004. |
| 2010-03-25 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2004. |
| 2011-03-24 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2004. |
| 2012-03-21 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2004 and as Chairman since December 2011. |
| 2013-03-20 | Joseph V. Gulfo, M.D. has served as our President and Chief Executive Officer and a member of our Board of Directors since January 2004 and as Chairman since December 2011. ... As an employee of the Company, Dr. Gulfo received no compensation for his services as a director. ... The following table sets forth the compensation earned by our principal executive officer and principal financial officer during our last three completed fiscal years, such officers are referred to herein as the "named executive officers." ... Joseph V. Gulfo, M.D., Chairman, President and Chief Executive Officer, 2012, Salary($) 313,600, Option Awards($) 0, Bonus($) 0, All Other Compensation($) 45,408, Total($) 359,008. |
Data sourced from SEC filings. Last updated: 2026-03-05